Interleukin-1beta increases urine flow rate and inhibits protein expression of Na(+)/K(+)-ATPase in the rat jejunum and kidney

J Interferon Cytokine Res. 2002 Oct;22(10):1041-8. doi: 10.1089/107999002760624279.

Abstract

The effect of interleukin-1beta (IL-1beta) on urine flow rates and Na(+)/K(+)-ATPase activity and expression was studied in rat intestinal and renal epithelia. The cytokine produced a significant diuretic effect and increased urine flow rate by around 10-fold compared with the control. This effect was considered to be secondary to the well-documented natriuretic effect of the cytokine described in the literature. On the other hand, we have shown previously that IL-1beta inhibits glucose absorption from the jejunum. As sodium excretion and glucose absorption are both dependent on Na(+)/K(+)-ATPase activity, the effect of the cytokine on the renal and intestinal pump was investigated. IL-1beta inhibited, in a dose-dependent manner, the activity of Na(+)/K(+)-ATPase in villus and crypt jejunal cells and in medullary and cortical kidney cells. Western blot analysis revealed a decrease in the protein expression of the enzyme, which was confirmed by the radiolabeled ouabain binding assay. The results suggest that the diuretic and natriuretic effect of IL-1beta and its inhibitory effect on glucose absorption are all due to downregulation of the Na(+)/K(+) pump in the kidney and jejunum.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diuresis / drug effects
  • Diuresis / physiology*
  • Enzyme Inhibitors / pharmacology
  • Interleukin-1 / pharmacology*
  • Jejunum / drug effects
  • Jejunum / enzymology
  • Jejunum / metabolism*
  • Kidney / drug effects
  • Kidney / enzymology
  • Kidney / metabolism*
  • Male
  • Ouabain / metabolism
  • Ouabain / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors*
  • Sodium-Potassium-Exchanging ATPase / drug effects
  • Sodium-Potassium-Exchanging ATPase / metabolism

Substances

  • Enzyme Inhibitors
  • Interleukin-1
  • Ouabain
  • Sodium-Potassium-Exchanging ATPase